This prospective observational cohort study was conducted over 8 months (December 2023 to July 2024) in Neurology ICU of a tertiary hospital and was conducted in accordance with the Declaration of Helsinki. After obtaining institutional ethics committee approval, the trial was registered in the Chinese Clinical Trial Registry (ChiCTR2400088210). Informed consent form was signed by the participant’s legal representative.
Eligibility criteria
Subjects included in the study should meet the following criteria: (1) Patients aged 18–80 years admitted to the NICU with planned elective extubation after 48 h of mechanical ventilation. (2) Patients with primary central nervous system injury, including stroke, status epilepticus, infectious and infectious encephalopathy, etc. The exclusion criteria are defined: (1) severe brain stem injury resulting in inability to breathe spontaneously. (2) history of abdominal surgery. (3) uncontrolled respiratory and circulatory diseases, including heart failure, pneumothorax, severe emphysema, pulmonary hypertension, uncontrolled asthma, etc.
Extubation Protocol
Extubation Protocol
Physicians, who were not involved in the study and blinded to the study findings, took the decision for extubation. All patients should meet the following criteria before extubation: hemodynamic stability without vasoactive drug, a successful spontaneous breathing trial (SBT) for at least 30 minutes, a successful cuff leak test, fraction of inspired oxygen (FiO2) < 40%, positive end-expiratory pressure (PEEP) < 5 cmH2O. Patients were followed up for 48 hours after extubation.
Data Collection
The demographic and clinical characteristics (age, sex, diagnosis, intubation method, intubation diameter, duration of mechanical ventilation, weaning and ICU stay) were collected. Ultrasound examination was performed before extubation. All variables were measured three times, and the average was included in the analysis. EF is defined as reintubation or initiation of unplanned non-invasive ventilation within 48h after extubation13.
Measurements
The ultrasonography device used in this study was GE LOGIQ E10s with a 10–15 MHz linear probe and a 3.5–5 MHz phased array probe. Ultrasound examination was performed by an experienced and qualified physiotherapist. All measurements were taken with patients in the supine position. To reduce variability, all measurements were taken three consecutive times at the same location and the average was calculated.
Abdominal muscle Ultrasound
A high-frequency (10–15 MHz probe) linear array transducer was placed midway between the 12th rib and the iliac crest along the anterior axillary line for the measurement of external oblique muscle (EO), internal oblique muscle (IO) and transversus abdominis (TrA). Rectus abdominis (RA) was measured with the probe placing 2 to 3 cm above the umbilicus, 2 to 3 cm to the right of the midline14. Pressure applied to the probe should be kept to a minimum to prevent compression of the abdominal wall, as this may change the thickness of the underlying muscles14.
Each muscle was first found in B mode, then the thickness is measured in M mode. Abdominal muscle thickness was measured under tidal breathing and coughing. For patients who can cooperate, Patients were asked to cough three times actively as much as possible. For patients who were not cooperative, cough was stimulated by pinching the suprasternal trachea or by inserting a sputum suction tube into airway. Thickness of each muscle was measured at end-inspiratory (Tei) and maximum cough (Tcough), as shown in Fig. 1 and Fig. 2. Muscle thickness is defined as the distance between the inner layers of each muscle, excluding surrounding aponeurosis. Cough Thickening fraction of abdominal muscle (cough TFabd) was computed as the percent change in thickness between end-inspiration and maximum cough (cough TFadb = (Tcough-Tei)/ Tei)×100%).
Diaphragm Ultrasound
Diaphragm excursion is performed using a 3.5–5 MHz phased array probe. The probe is placed below the right costal arch at the midclavicular line, with the direction as perpendicular to the movement direction of the dome roof. The M-mode is then used to display the motion of the anatomical structures along the selected line. Diaphragm excursion (DE) is the vertical distance between the starting point (beginning of inhalation) and the peak point (end of inhalation) and DE-Inspiratory time (s) is the horizontal distance between these two points. DE- contraction speed (cm/s) is the slope of DE and DE-Inspiratory time 15
Diaphragm thickness measurement is measured with a high-frequency (10-15MHZ) linear array probe, and the probe is placed perpendicular to the long axis of the ribs or parallel to the intercostal space at the 8th to 11th intercostal space in the front or midaxillary line. The diaphragm thickness is recorded at the end of inspiration (Tei) and end of expiration (Tee). The thickening fraction (TF) can be calculated using the M mode (TF = (Tei- Tee) / Tee).
Statistical Analysis
Descriptive statistics include frequency (percentages) for categorical variables and median and interquartile ranges (IQRs) for continuous variables. Chi-squared tests and Mann–Whitney U tests were used to compare categorical variables and continuous variables, respectively. The association between abdominal muscle and diaphragm function and the risk of extubation failure was assessed by using logistic regression. Indicators that are significantly related to extubation failure were assessed by using receiver operating characteristic (ROC) curve analysis to discriminate between extubation success/failure. The indicators which have the largest the area under the curve (AUC) was set the cutoff point based on The Youden Index. All tests were two-sided, and P values less than 0.05 were considered statistically significant. All statistical analyses were performed by using SPSS Statistics 26.0.
According to the extubation failure rate in patients with neurointensive care is around 20%2, A sample of 8 from the positive group and 32 from the negative group achieves 81% power to detect a difference of 0.3000 between the area under the ROC curve (AUC) under the null hypothesis of 0.8000 and an AUC under the alternative hypothesis of 0.5000 using a two-sided z-test at a significance level of 0.050.